兵团持续筑牢药品安全防线

Core Viewpoint - The Xinjiang Production and Construction Corps (XPCC) has launched a "Clean Source Action" to address prominent issues in the pharmaceutical distribution sector, focusing on comprehensive inspections and strict regulatory measures to enhance drug safety and compliance [1] Group 1: Regulatory Actions - The "Clean Source Action" involves a thorough inspection of pharmaceutical business practices, with a focus on risk assessment and enforcement of regulations [1] - Regulatory authorities have inspected 2,453 pharmaceutical enterprises at both the XPCC and division levels, mandating timely rectification of identified violations [1] Group 2: Focus Areas of Inspection - Inspections target key issues such as unauthorized business operations, procurement from illegal sources, tampering with computer system data, and failure to upload or verify drug traceability codes [1] - Multiple regulatory measures have been implemented to address industry irregularities, aiming to purify the pharmaceutical market environment and strengthen drug safety defenses [1]